CR BARD INC
Sector: Indices SP 500
Latest Quote @ Sun Dec 12 10:11:32 (15 min delayed)
Last Day's Data
C. R. Bard, Inc. (Bard) engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices. It has four product groups: Vascular, Urology, Oncology, and Surgical Specialties. In the Vascular products group, the company offers products for the peripheral vascular market. These products include percutaneous transluminal angioplasty catheters, guidewires, introducers and accessories, peripheral stents, vena cava filters, and biopsy devices; electrophysiology products, including diagnostic, therapeutic, and temporary pacing electrode catheters; and fabrics, meshes, and implantable vascular grafts. In the Urology products group, Bard offers foley catheters; surgical sling and injectable tissue bulking products that are used to treat stress urinary incontinence; natural and synthetic materials for the treatment of pelvic floor or vaginal prolapse; brachytherapy services, devices, and radioactive seeds that are used to treat prostate cancer; urine monitoring and collection systems; ureteral stents; and specialty devices for ureteroscopic procedures and stone removal. The company's Oncology products include devices used in the treatment and management of various cancers, and other diseases and disorders. These include specialty access catheters, ports, and enteral feeding devices. Bard's Surgical Specialty products include meshes for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. It sells its products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities worldwide. Bard distributes its products directly and through distributors. The company was founded in 1907 by Charles Russell Bard and is headquartered in Murray Hill, New Jersey.